The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisis.
Bambauer
Kara Zivin
KZ
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA.
Sabin
James E
JE
Soumerai
Stephen B
SB
D001569:Benzodiazepines / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003419:Crisis Intervention; D006292:Health Priorities / Q000191:economics / Q000331:legislation & jurisprudence*; D006301:Health Services Needs and Demand / Q000191:economics; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D014481:United States
D001569:Benzodiazepines